Mentice AB (OSTO:MNTC) Research & Development: kr0.0 Mil (TTM As of Mar. 2026)


OSTO:MNTC Mentice AB OSTO:MNTC
76 GF Score
Price kr13.05
GF Value kr26.00
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Mentice AB Research & Development?

Mentice AB OSTO:MNTC +0.38% 76 Research & Development is kr0.0 Mil as of Mar. 2026. GuruFocus rates OSTO:MNTC with a GF Score™ of 76/100 and a GF Value™ of kr26.00 (Possible Value Trap). The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Mentice AB's Research & Development for the three months ended in Mar. 2026 was kr0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was kr0.0 Mil.

Mentice AB  (OSTO:MNTC) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Mentice AB Research & Development Related Terms

Mentice AB Research & Development Historical Data

* Premium members only.

The historical data trend for Mentice AB's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mentice AB Research & Development Chart

Mentice AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

Mentice AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
OSTO:MNTC
76GF Score
Mentice AB OSTO:MNTC
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mentice AB Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of kr0.0 Mil mean?
Mentice AB (OSTO:MNTC) has a Research & Development of kr0.0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Mentice AB and its competitors.
Is Mentice AB's Research & Development too high?
Mentice AB's current Research & Development is kr0.0 Mil. Overall, Mentice AB has a GF Score™ of 76/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Mentice AB's Research & Development compare to ABT and SYK?
Mentice AB's Research & Development of kr0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Mentice AB and its competitors. Mentice AB's current Research & Development is kr0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mentice AB stock overvalued right now?
Based on GuruFocus' analysis, Mentice AB (OSTO:MNTC) is currently considered Possible Value Trap. The stock's GF Value™ is kr26.00, compared to a current price of kr13.05 — trading 49.8% below its estimated fair value. The current Research & Development is kr0.0 Mil. Mentice AB's overall GF Score™ is 76/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Mentice AB (OSTO:MNTC), the current Research & Development is kr0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mentice AB (OSTO:MNTC) Overvalued in 2026?

Based on GuruFocus' analysis, Mentice AB stock appears to be undervalued. The current stock price of kr13.05 is trading 49.8% below its estimated GF Value™ of kr26.00. GuruFocus considers Mentice AB to be Possible Value Trap.

Key valuation signals for OSTO:MNTC:

  • Research & Development: kr0.0 Mil
  • GF Value™: kr26.00 vs. price of kr13.05 (49.8% below fair value)
  • GF Score™: 76/100 with 2 warning signs

No single metric tells the full story. See the OSTO:MNTC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mentice AB Business Description

Other Exchanges MN2:Germany
Address Odinsgatan 10, Gothenburg, SWE, 411 03
Mentice AB is a provider of software and hardware simulation solutions for image guided interventional therapies, offering proficiency based simulation solutions that help healthcare professionals acquire, retain, and enhance procedural skills, improving productivity and outcomes. Its solutions are scientifically validated and developed for healthcare providers and the medical device industry. Neurovascular, cardiovascular, and peripheral interventions are covered. Mentice operates in two segments: Medical Device Industry (MDI), providing end-to-end solutions supporting development and launch of interventional therapies, and Healthcare Systems (HCS). Product areas include Mentice VIST, Physical Sim, Mentice Live, and Ankyras. It operates in EMEA, APAC, and the Americas.
76GF Score

Get the complete analysis for OSTO:MNTC

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr13.05
Price
kr26.00
GF Value